Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US National Institutes of Health (NIH) offers Creutzfeldt Jakob Disease (CJD) test licence:

This article was originally published in Clinica

Executive Summary

The US National Institutes of Health is offering a non-exclusive licence to the 14-3-3 protein test for spongiform encephalopathies, which was published by the New England Journal of Medicine in September (see Clinica No 725, p 15). Enquiries concerning the NIH licence should be addressed to Dr George Keller, Office of Technology Transfer. Tel: +1 301 496 7735 ext 246. Fax: +1 301 402 0220.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel